ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME: CHOOSING THE BASIS MEDICATION
The aim of the study was to assess the effectiveness of Accupro (Quinapril; 40 mg/d), as monotherapy and basis medication of combined therapy, in the treatment of arterial hypertension (AH) among patients with metabolic syndrome (MS). After 8 weeks of Accupro monotherapy (40 mg/d), target levels of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2011-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The aim of the study was to assess the effectiveness of Accupro (Quinapril; 40 mg/d), as monotherapy and basis medication of combined therapy, in the treatment of arterial hypertension (AH) among patients with metabolic syndrome (MS). After 8 weeks of Accupro monotherapy (40 mg/d), target levels of blood pressure (BP) were achieved in 68% of the patients. BP normalization correlated with endothelial function improvement. Accupro therapy (40 mg/d) was also well tolerated. Accupro (40 mg/d) could be recommended as an effective and safe basis medication for combined antihypertensive therapy in patients with AH and MS. |
|---|---|
| ISSN: | 1560-4071 2618-7620 |